Kelly Price has a strong background in pharmaceuticals and healthcare, with experience in market access, patient advocacy, and sales. With a Bachelor of Science in Nursing from Baylor University, Kelly has held various leadership positions in companies such as HRA Pharma, Mahana Therapeutics, and Direct Success, Inc. Currently serving as the US Head of Rare Disease at HRA Pharma, Kelly brings a wealth of knowledge and expertise to their role.
Current role